Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO Virtual Preceptorship on Metastatic Bladder and Kidney Cancer 2020

ESMO-Preceptorship-Metastatic-Bladder-Kidney-Cancer-Virtual-2020-1000x250
Start date
02 Sep 2020
End date
03 Sep 2020
Application deadline
31 Jul 2020

Learning objectives

  • To learn about fundamentals of molecular pathology and diagnosis as contributing factors to heterogeneity in bladder and kidney cancer
  • To understand essentials in the assessment and multidisciplinary treatment of bladder and kidney cancer
  • To learn about advances in treatment and novel targets in bladder and kidney cancer

Download the preliminary programme

Apply now! 

How to apply

Application is via online form. During the application process you will be required to upload the following:

Application deadline

Application for the online course will close on 31 July 2020.

Who can apply?

While this online course is primarily aimed at oncologists resident in Asia, application is open to all ESMO members.

Please kindly note that the virtual course programme timings are to be considered GMT +8.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

What's included?

Successful applicants will benefit from complimentary registration for this virtual course.

Accreditation

The programme of this virtual event will be accredited with ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.

Co-Chairs

  • Aristotelis Bamias, Greece
  • Ravindran Kanesvaran, Singapore

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings